Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation

Nafamostat, a serine proteinase inhibitor with various actions including antithrombin, antiplasmin, and antitrypsin effects, has been used in clinical practice to treat disseminated intravascular coagulation (DIC) and pancreatitis. This case report describes the clinical course of a patient with COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Wakana, Yoneda, Taro, Koba, Hayato, Ueda, Tsukasa, Tsuji, Noriaki, Ogawa, Haruhiko, Asakura, Hidesaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607231/
https://www.ncbi.nlm.nih.gov/pubmed/33157292
http://dx.doi.org/10.1016/j.ijid.2020.10.093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607231/
https://www.ncbi.nlm.nih.gov/pubmed/33157292
http://dx.doi.org/10.1016/j.ijid.2020.10.093

Ejemplares similares